Peripheral cases
Turbo-Tandem Laser Device to Treat Patient with In-stent Restenosis of a Long SFA Nitonol Stent – Oct 2014

| | | | | |

Views 787

This is a patient who has Rutherford Class III symptoms with in-stent restenosis of a long SFA Nitonol Stent. We will demonstrate how to safely navigate the occlusion and use the Turbo-Tandem laser device to treat this difficult lesion. As you know, there is no consensus as to how to treat SFA ISR. We will take this opportunity to discuss the recent literature and relevant trials in order to create better understanding among endovascular interventionalists as to how to best treat this complex disease condition.



Leave a Reply

Your email address will not be published. Required fields are marked *

Views 197

Case and Plan: 55 year-old-male with mutliple comorbidities, who presents with ongoing, bilateral lifestyle-limiting claudication now progressed to rest pain (L>R) who is status post R SFA CTO intervention and now planned for L SFA CTO intervention via femoral approach.

Transradial Approach for CFA Intervention Involving Fem-Fem Bypass Graft – July 2020
Views 172

Case and Plan: 70 year-old male with a PMHx of HTN, HLD, asthma, NIDDM, CKD Stage III, HFpEF (55%), MGUS, CAD s/p 2vCABG and PAD s/p bilateral common iliac stent c/b left common iliac artery stent occlusion s/p R->L fem-fem bypass who is presenting with progressive claudication now present at rest (Rutherford 4). Lower extremity […]

Chronic total occlusion (CTO) of left popliteal artery – June 2020
Views 671

Case and Plan: This is a 68 F with hypertension, diabetes, dyslipidemia and peripheral arterial disease who had prior interventions of the right lower extremity. She presented to the office with life style limiting claudication that has progressed to pain at rest despite optimal medical and exercise therapy. Non invasive studies showed severely reduced ABI […]

Management of CLI and ALI During the COVID-19 Pandemic – May 2020
Views 345

Case and Plan: Live Discussion with Q&A on “Management of CLI and ALI During the COVID-19 Pandemic